Adaptation of SARS-CoV-2_Engl2 to VeroE6 and selection of decreased RDV sensitivity. حسب Agnieszka M. Szemiel (10196243)

Image_2_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.JPEG حسب Meijuan Liu (4924417)

"…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. The combination of ZAG with other clinical variables including age, gender, BMI, SBP, FBG, TC, HDL-C, Cr, and Urea had significantly improved the diagnosis accuracy with a sensitivity of 82.6%, a specificity of 95.0%, and AUC of 0.957 (95% CI, 0.940–0.975, p < 0.05).…"

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. حسب Rozita Mohd (7411322)

Percentage of violacein production in <i>Chromobacterium violaceum</i> by the most active synthesized 1,2,3,5-tetrazine derivatives (4a, 4b and 4c). حسب Jean Paul Dzoyem (6424445)

الموضوعات:

The treatment with anti-CXCR3 decreases the number of CD8⁺ T cells in the heart. حسب Camila Pontes Ferreira (6194006)

Effect of NAC on decreased MYH expression caused by arecoline in C2C12 cells. حسب Yi-Xuan Li (6633845)

Effect of NAC on decreased myogenin expression caused by arecoline in C2C12 cells. حسب Yi-Xuan Li (6633845)

Two hypothesized models for C period decrease as growth rate increases. حسب Sara Sanders (4163479)

FTY720 treatment decreased phosphorylation of AKT, ERK, and c-myc. حسب Laura L. Stafman (6577184)

"…(B) Immunoblotting for the activated form of ERK1/2 –phospho-ERK1/2 (Thr202/Tyr204, Thr185/Tyr187)–and total ERK1/2 revealed a decrease in phospho-ERK1/2 with no accompanying change in total ERK1/2, indicating a decrease in ERK signaling with FTY720 treatment. …"

The inhibitory activity of the most active compounds against Glo-I enzyme with less than 50 µM. Their supportive corresponding docking values on two different protocols are display... حسب MohammedBashar Al-Qazzan (22439236)

Simulated effects of increased pCREB combined with decreased pCaMKIIα on time courses of molecular pathways and synaptic weight W after IA training. حسب Yili Zhang (540283)

"…(B) Example of dynamics of BDNF protein/mRNA (B1-2), C/EBPβ protein (B3), pCREB (B4), pCaMKIIα (B5), Sin3a binding (B6), MeCP2 binding (B7), HDAC2 binding (B8), and W (B9), with the standard parameter values in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1010239#pcbi.1010239.t001" target="_blank">Table 1</a> (black dashed) or with <i>k</i>_{<i>basalp_creb</i>} increased by ~50% and <i>k</i>_{<i>basalp_CaMKII</i>} decreased by ~50% from control combined with higher binding levels of MeCP2, Sin3a and HDAC2 (blue) to simulate IA conditioning in infant rats. …"

Effect of seed priming on anti-oxidants and lipid peroxidation in pearl millet at 50 DAS. حسب N. K. Gupta (11211399)

الموضوعات:

Loss of <i>jag1b</i> function decreases the penetrance of <i>mef2ca</i>-associated phenotypes. حسب Juliana Sucharov (8067371)

"…Removing functional copies of <i>jag1b</i> decreased <i>mef2ca</i> mutant penetrance. Scale bar: 50 μm. …"

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. حسب Hiu Ham Lee (15374677)

AIM-100 reduces dsRNA silencing in body wall muscle and decreases DA neurodegeneration. حسب Anthony L. Gaeta (13272609)

Transgenic FAR expression significantly decreases fly survival and increases bacterial load 24-hours post-injection. حسب Sophia C. Parks (11624976)

Temperature field considering the insulation layer deterioration (2.6 °C). حسب Jianqing Jia (21001506)

Taste bud cell populations are decreased after <i>Sox2</i> deletion in epithelial stem/progenitor cells. حسب Makoto Ohmoto (3065106)

M344 decreases orthotopic pancreatic tumor growth when used as a treatment alone or in combination with gemcitabine. حسب Shelby M. Knoche (13833807)

Cell line characterization and combination effect of KRAS G12C inhibitors and pemigatinib. حسب Angela Abdollahi (15166230)